FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

Health Canada Adopts ICH Guidance on Multi-Regional Clinical Trials

April 24, 2019

Canadian regulators have adopted ICH’s E17 guidelines on multi-regional trials.

The agency said current Health Canada guidance may not be entirely consistent with the ICH document, but the Health Canada-implemented ICH guidance will take precedence in such cases.

The adoption comes nearly two years after ICH finalized the E17 document. European and American regulators adopted the guidelines last year.

View today's stories